NCT06693492

Brief Summary

Disorders of consciousness (DOC) diagnosis suffers from the difficulty to measure the level of consciousness due to the variability associated with behavioural assessments and the difficulty in detecting the residual level of consciousness in patients who do not show any behavioural signs during the behavioural assessment. This issue could be overcome by using instrumental tools, that are expensive and not always available in clinical settings. The ultrasound-based techniques could represent a valid low-cost and more feasible alternative to deep the knowledge about physio-pathological mechanisms underlying DOC and their chronicization. These techniques could be tailored to treat acute and chronic DOC patients from a personalised medicine perspective. Improving the knowledge, management and care pathways of DOC patients and finding new therapeutic options would benefit not only patients but also public health systems.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
May 2023May 2026

Study Start

First participant enrolled

May 20, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2023

Completed
11 months until next milestone

First Posted

Study publicly available on registry

November 18, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2026

Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

3 years

First QC Date

December 21, 2023

Last Update Submit

February 10, 2026

Conditions

Keywords

disorders of consciousnessultrasoundneuromodulationminimally conscious statevegetative stateunresponsive wakefulness syndrome

Outcome Measures

Primary Outcomes (1)

  • Brain ultrasonography measures

    These data are based on ultrasound parameters extracted from the ultrasound assessment protocol

    T0 (time of enrolment) and T1 (at 6 months from the enrolment for the chronic patients; at 1 year from the acute event for the post-acute patients)

Secondary Outcomes (5)

  • Level of Consciousness

    T0 (time of enrolment) and T1 (at 6 months from the enrolment for the chronic patients; at 1 year from the acute event for the post-acute patients)

  • Coma-to-Community outcome measures

    T0 (time of enrolment) and T1 (at 6 months from the enrolment for the chronic patients; at 1 year from the acute event for the post-acute patients)

  • Coma-to-Community outcome measures

    T0 (time of enrolment) and T1 (at 6 months from the enrolment for the chronic patients; at 1 year from the acute event for the post-acute patients)

  • Neuroendocrine, inflammatory, and nutritional markers derived from a blood sample

    T0 (time of enrolment)

  • EEG connectivity measures

    T0 (time of enrolment)

Study Arms (2)

Chronic patients (DOC duration >=1 year)

EXPERIMENTAL

* Assessment with US technique to characterized the pathophysiological features of chronic DOC * For the Interventional part of the project, the selected patients in this arm will be treated with a single session of US neuromodulation and the following measures will be collected before and after the intervention: Coma Recovery Scale-revised; Resting state fMRI; EEG-based neurophysiological indices

Device: Ultrasound technique for diagnosis; Focused Ultrasound Stimulation for intervention

Post-acute patients (DOC duration <1 year)

EXPERIMENTAL

* Assessment with US technique to characterized the pathophysiological features of post-acute DOC and explore its predictive value for chronicization * For the Interventional part of the project, the selected patients in this arm will be treated with a single session of US neuromodulation and the following measures will be collected before and after the intervention: Coma Recovery Scale-revised; Resting state fMRI; EEG-based neurophysiological indices

Device: Ultrasound technique for diagnosis; Focused Ultrasound Stimulation for intervention

Interventions

Both chronic and post-acute patients are evaluated through the ultrasound technique to further characterize the mechanisms underlying DOC following acquired brain injuries (e.g., stroke, traumatic brain injury, anoxic events). Furthermore, the predictive value of structural and functional markers for DOC chronicization is explored by following up post-acute DOC patients 1 year after the acute event. Finally, to innovate the therapeutic approach to DOC patients, we adopt the low-intensity focused ultrasound (FUS) on a group of selected 10 patients out of the 100 DOC patients enrolled in the study to modulate brain networks' functioning targeting key brain structures for the recovery of consciousness.

Chronic patients (DOC duration >=1 year)Post-acute patients (DOC duration <1 year)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • an established diagnosis of DOC (UWS or MCS according to the CRS-R criteria and/or a CRS-R total score ≤22) following severe acquired brain injury;
  • age\>18 years old;
  • written informed consent obtained from each patient's representative.

You may not qualify if:

  • previous psychiatric, neurological, or drug abuse history;
  • on-going mechanical ventilation.
  • From the population enrolled for aim 1, we plan to select ten patients
  • \<age\<65 years;
  • medical stability over the previous 30 days;
  • presence of the following US variables: low brain stiffness, high elasticity, and adequate level of tissue perfusion;
  • written informed consent obtained from each patient's representative;
  • structural integrity of both thalami as assessed by MRI.
  • Exclision criteria:
  • contraindications to MRI examination;
  • presence of decompressive craniectomy or cranioplasty performed within 30 days;
  • presence of epileptogenic features on the EEG and/or drug resistant epileptic crisis history;
  • presence of severe muscoloskeletal impairments which are likely to interfere with the correct positioning required for the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Istituto S. Anna, Semi-Intensive Rehabilitation Unit for Acquired Brain Injury

Crotone, Calabria, 88900, Italy

RECRUITING

IRCCS Istituto delle Scienze Neurologiche di Bologna, UO di Medicina Riabilitativa e Neuroriabilitazione

Bologna, Emilia-Romagna, 40139, Italy

RECRUITING

Fondazione IRCCS Istituto Neurologico C. Besta, Neurology, Public Helath, Disability Unit

Milan, Lombardy, 20133, Italy

RECRUITING

IRCCS Centro Neurolesi Bonino Pulejo, Neuroimaging Lab

Messina, Sicily, 98124, Italy

RECRUITING

MeSH Terms

Conditions

Consciousness DisordersPersistent Vegetative State

Interventions

UltrasonographyDiagnosisMethods

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesUnconsciousness

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresInvestigative Techniques

Central Study Contacts

Francesco Ugo Prada, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Longitudinal prospective cohort study with baseline and follow-up assessment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2023

First Posted

November 18, 2024

Study Start

May 20, 2023

Primary Completion (Estimated)

May 19, 2026

Study Completion (Estimated)

May 19, 2026

Last Updated

February 12, 2026

Record last verified: 2026-02

Locations